Resistance in hematologic malignancies and cancer /

Resistance in Hematologic Malignancies and Cancer brings together the molecular, cellular, and biochemical basis/principles of various mechanisms of resistance to treatment in hematologic malignancies. Even though main mechanisms of resistance are the same in different types of tumours there are spe...

Full description

Bibliographic Details
Corporate Author:	ScienceDirect (Online service)
Other Authors:	Messingerova, Lucia (Editor), Breier, Albert (Editor)
Format:	eBook
Language:	English
Published:	London, United Kingdom : Academic Press, [2025]
Series:	Cancer sensitizing agents for chemotherapy ; volume 22
Subjects:	Drug resistance in cancer cells. Blood > Cancer > Chemotherapy. Hematological oncology. Drug Resistance, Neoplasm Cellules cancéreuses > Résistance aux médicaments. Hématocancérologie. Electronic books.
Online Access:	Connect to the full text of this electronic book

Table of Contents:

Front Cover
Resistance in Hematologic Malignancies and Cancer
Copyright
Cover Image Insert
Aims and Scope for Series ``Cancer Sensitizing Agents for Chemotherapy´´
About the Series Editor
Acknowledgments
Aims and Scope of Volume
Volume Editor Biography
Preface
Contents
Contributors
Chapter 1: Drug classification for the treatment of hematologic malignancies
Introduction
Chemotherapeutic drugs
Alkylating agents
Antimetabolites
Natural alkaloids with antitubulin activity
Cytotoxic antibiotics
Fixed-dose combination drugs
Small-molecule anticancer drugs
Tyrosine kinase inhibitors
Multikinase inhibitors
Phosphatidylinositol 3-kinase inhibitors
Enzyme inhibitors
Histone deacetylase inhibitors
Isocitrate dehydrogenase inhibitors
Enhancer ofzZeste homolog 2 inhibitor
DNA and RNA methyltransferases inhibitor
Smoothed receptor antagonists